Evaluation of nausea and vomiting in chemotherapy patients.
Conditions
Interventions
Intervention group: Patients who want to enter the study group enter groups A and B based on random division, which is a lottery, and at the end of the study, after analyzing the data, the nature of t
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Over 18 years old, with malignant cancer confirmed by oncologist based on pathological result Moderately emetogenic highly multi drug regimens or highly emetogenic single drug regimens based on the ESMO clinical guideline Undergoing chemotherapy with cisplatin and anthracyclines
Exclusion criteria
Exclusion criteria: History of chronic underlying disease Simultaneous abdominal radiotherapy History of severe digestive problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of the paste on reducing nausea and vomiting caused by chemotherapy. Timepoint: The effect of QUINCE on nausea and vomiting in chemotherapy patients from 5 days before chemotherapy to 5 days after chemotherapy. Method of measurement: The effect of paste on nausea and vomiting in chemotherapy patients is how the outcome variable can be measured (Common Terminology Criteria for Adverse Events (CTCAE) checklist). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaedeh Rast
Sabzevar University of Medical Sciences
Outcome results
None listed